Akrimax buys Wyeth plant
This article was originally published in The Tan Sheet
Executive Summary
Emerging company Akrimax Pharmaceuticals has acquired Wyeth's drug product manufacturing and packaging plant in Rouses Point, N.Y., the company announces Jan. 15. The companies will slowly transition production at the facility with Wyeth continuing to make products there through the end of 2009. Akrimax says it plans to hire Wyeth's workforce at the site, which includes nearly 800 manufacturing jobs...